Effect of Multiple Doses of Montelukast, a CysLT1Receptor Antagonist, on Digoxin Pharmacokinetics in Healthy Volunteers-Reference-Cited by-同舟云学术

Effect of Multiple Doses of Montelukast, a CysLT1Receptor Antagonist, on Digoxin Pharmacokinetics in Healthy Volunteers

Published:1999-09 Issue:9 Volume:39 Page:941-944
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Depré Marleen,van Hecken Anne,Verbesselt René,Wynants Katleen,De Lepeleire Inge,Freeman Amanda,Holland Sherry,Shahane Aditi,Gertz Barry,De Schepper Paul J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist;Jones;Can J Physiol Pharmacol,1995

2. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma;Lepeleire;Clin Pharm Ther,1997

3. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma;Reiss;J Allergy Clin Immunol,1996

4. Pharmacokinetics, bioavailibility, and safety of montelukast sodium (MK-0476) in healthy males and females;Cheng;Pharm Res,1996

5. Pharmacokinetic interactions with digoxin;Rodin;Clin Pharmacokin,1988

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategy for the Prediction of Steady-State Exposure of Digoxin to Determine Drug–Drug Interaction Potential of Digoxin With Other Drugs in Digitalization Therapy;American Journal of Therapeutics;2019-01

2. Design and Data Analysis in Drug Interaction Studies;Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions;2018

3. Design and Data Analysis in Drug Interaction Studies;Drug Interactions in Infectious Diseases;2011

4. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans;British Journal of Clinical Pharmacology;2007-03

5. Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma;Drug Safety;2003